Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Daily News

Palliative Care in HF: Practical Advice From the HFSA

Caitlin E. Cox

December 05, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

Todd Neale

June 28, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Daily News

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

L.A. McKeown

May 15, 2024

News Daily News

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

Caitlin E. Cox

April 22, 2024

News Daily News

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Yael L. Maxwell

April 18, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

Caitlin E. Cox

March 13, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT Abstracts 2024

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Presenter: Jennifer Cowger

March 05, 2024

Presentation THT Abstracts 2024

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Presenter: John Eisenga

March 05, 2024

Presentation THT 2024

Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

Presenter: Palak Shah

March 05, 2024

Presentation THT Abstracts 2024

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Presenter: Timothy George

March 04, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

News Daily News

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

Todd Neale

January 23, 2024

Advertisement

Palliative Care in HF: Practical Advice From the HFSA

November 2024 Dispatch for the CV Team

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

TCTMD’s Top 10 Most Popular Stories for May 2024

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Cognitive Impairment a Real Concern in HF Patients: HFSA

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content